Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-10-02
1993-12-21
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 43, 514285, 514908, 536 55, 536 271, 544125, 546 70, A61K 31435, A61K 31535, C07D47104
Patent
active
052721469
ABSTRACT:
Certain new 1,2-dihydroellipticine compounds having activity against CNS specific cancer cell lines because of their ease of passage across the blood-brain barrier are disclosed along with formulations and methods for treating CNS cancers employing these compounds.
REFERENCES:
patent: 4045565 (1977-08-01), Le Pecq et al.
patent: 4310667 (1982-01-01), Le Pecq et al.
patent: 4479932 (1984-10-01), Bodor
patent: 4698423 (1987-10-01), Honda et al.
Fishman, Am. J. Physiol., 206, 836 (1964).
Guthrie et al., J. Medicinal Chemistry, 18(7), 755 (1975).
Ross and Froden, Eur. J. Pharmacol., 13, 46 (1970).
Rouesse et al., Bull. Cancer (Paris), 68, 437 (1981).
Ali-Osman et al., Cancer Research 45, 2988-2992 (Jul. 1985).
Boyd, Principles & Practice of Oncology, 3(10), 1 (1989).
Boyd et al., Anticancer Drug Discovery and Development, (Eds: Valeriote, F. A. Corbett, T., Baker, L.), Amsterdam, Kluwer Academic Publishers (in press, 1990).
Gibson J.C.S. Chem. Comm., 815 (1977).
Gribble, The Alkaloids, 7, 239 (1990).
Juret et al., Europ. J. Cancer, 14, 205-206 (1978).
Monks et al., J. National Cancer Institute, 83(11), 757 (1991).
Narayanan, Dr. Ven. L., 1992 AACR Abstract Forms.
Pop et al., Drugs of the Future 1991, 16(3), 221-248 (1991).
Werbel et al., J. Med. Chem., 29, 1321 (1986).
Wijsmuller et al., Heterocycles, 24(7), 1795 (1986).
Auclair, Chemical Abstracts, vol. 115 (1991) No. 64134x.
Auclair, Chemical Abstracts, vol. 114 (1991) No. 199068d.
Zee et al, Chemical Abstracts, vol. 109 (1988) No. 55024k.
Weller et al, Chemical Abstracts, vol. 101 (1984) No. 111,238g.
Buechi et al, Chemical Abstracts, vol. 56 (1962) 11632e.
Lehner et al, Chemical Abstracts, vol. 57 (1962) 3499c.
Govindacheri et al, Chemical Abstracts, vol. 59 (1963) 11586f.
Cushman Mark
Haugwitz Rudiger D.
Jurayj Jurjus
Narayanan Venkatachala L.
Purdue Research Foundation
Ramsuer Robert W.
The United States of America as represented by the United States
LandOfFree
1,2-dihydroellipticines with activity against CNS specific cance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2-dihydroellipticines with activity against CNS specific cance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2-dihydroellipticines with activity against CNS specific cance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309181